Value-Based Pricing: L'Enfant Terrible?
Pharmacoeconomics
.
2018 Jan;36(1):5-6.
doi: 10.1007/s40273-017-0567-4.
Authors
Sarah Garner
1
,
Andrew Rintoul
2
,
Suzanne R Hill
3
Affiliations
1
Innovation, Access and Use, Department of Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland. garners@who.int.
2
Innovation, Access and Use, Department of Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland.
3
Department of Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland.
PMID:
29270834
PMCID:
PMC5775381
DOI:
10.1007/s40273-017-0567-4
No abstract available
Publication types
Letter
Comment
MeSH terms
Costs and Cost Analysis
Health Care Costs*
Quality of Health Care*
Grant support
001/World Health Organization/International